Trade Secrets

The IP dangers in life sciences collaborations and how to avoid them

Partnership agreements are a growing part of the biopharma R&D process, so anticipating potential pitfalls in such arrangements is vital

The IP dangers in life sciences collaborations and how to avoid them
Research confirms trade secret protection now a major boardroom issue
9 Jun 2021

Research confirms trade secret protection now a major boardroom issue

Multi-jurisdictional survey of over 300 senior executives in six industries identifies cybersecurity and employee leaks as the two major vulnerabilities

Battle over aircraft start-up shows why Chinese investments fuel IP fears
9 Jun 2021

Battle over aircraft start-up shows why Chinese investments fuel IP fears

Investors file Delaware lawsuit in bid to block IP deal with Chinese company

Latest

View all
8 Jun 2021

South Korea’s strategic approach to IP sets up key global deals

Agreements around chips and vaccines show that IP-related issues are high on the diplomatic agendas of advanced economies Read more

2 Jun 2021

Zespri asks kiwifruit growers to explore a deal in China to address unauthorised plantings

Co-operative of New Zealand producers warns that plant variety litigation is unlikely to succeed on its own Read more

26 May 2021

Xi Jinping throws weight behind TRIPS waiver, but don’t expect China to invoke flexibilities

Chinese leader called on the WTO to make an “early decision” on whether to suspend IP protections for covid-19 vaccinations Read more

21 May 2021

President Biden finds himself caught between a rock and a hard place on the covid vaccine IP waiver

The administration's backing for a suspension looks increasingly like coming with heavy political and economic costs Read more

News

View all
8 May 2021

Biden’s backing for the covid vaccine IP waiver should concern all rights owners

This week’s unprecedented move raises a series of worrying questions and puts in doubt the administration’s commitment to fostering innovative activity Read more

19 Nov 2020

Your guide to covid-19 vaccine stakeholders’ IP strategies

IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations Read more

9 Nov 2020

Pfizer’s covid vaccine found 90% effective, but raises IP questions

Company CEO proclaims “a great day for science and humanity”, but there are patent, know-how and data uncertainties to overcome Read more

28 Oct 2020

Help us to identify the world's leading IP strategists

The research process for the IAM Strategy 300 2021 is now underway and we are inviting nominations as we decide who should be included Read more

Analysis

View all
10 May 2021

Beware unintended consequences of proposals to tackle IP theft, warns trade secrets guru

With a growing number of bills aimed at China, Jim Pooley warns that harsh measures could prompt a tit-for-tat response against US rights owners Read more

6 May 2021

Biden backs covid-19 IP waiver in historic US policy shift

Landmark move suggests realignment in America’s domestic and international healthcare IP stance Read more

3 May 2021

New report lays bare the worrying extent of the UK's IP malaise

British companies lag their competitors on a number of measures, as well as on business investment in R&D, according to research published today Read more

28 Apr 2021

China bill moving through US Senate would create list of ‘IP violators’

The Strategic Competition Act of 2021 could also see increased use of sanctions to combat IP theft Read more

Insights

View all
8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more